Navigation Links
Argos Therapeutics Files Registration Statement for Proposed Initial Public Offering
Date:7/29/2011

DURHAM, N.C., July 29, 2011 /PRNewswire/ -- Argos Therapeutics, Inc. today announced that it has filed a registration statement on Form S-1 with the U.S. Securities and Exchange Commission (SEC) relating to a proposed initial public offering of shares of its common stock. All shares of the common stock to be sold in the offering will be offered by the company.

Lazard Capital Markets LLC and Canaccord Genuity Inc. are acting as joint book-running managers for the offering.  Needham & Company, LLC and BMO Capital Markets Corp. are acting as co-managers.  

A registration statement relating to these securities has been filed with the SEC but has not yet become effective. These securities may not be sold, nor may offers to buy be accepted, prior to the time the registration statement becomes effective. This news release shall not constitute an offer to sell or a solicitation of an offer to buy, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful, prior to registration or qualification under the securities laws of any such state or jurisdiction

The offering will be made only by means of a prospectus.  When available, copies of the preliminary prospectus relating to and describing the terms of the offering may be obtained from Lazard Capital Markets, Attn: Syndicate Department, 30 Rockefeller Plaza, 60th Floor, New York, NY 10020, phone: (800) 542-0970 or Canaccord Genuity, Attn: Syndicate Department, 99 High Street, 12th Floor, Boston, MA 02110, phone: (800) 225-6201.

About Argos Therapeutics

Argos Therapeutics is a biopharmaceutical company focused on the development and commercialization of fully personalized immunotherapies for the treatment of cancer and infectious diseases based on its Arcelis™ technology platform. Using biological components from each patient, Arcelis-based immunotherapies employ the patient's den
'/>"/>

SOURCE Argos Therapeutics, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Argos Therapeutics Arcelis™ Immunotherapy for the Treatment of Renal Cell Carcinoma (RCC) in Combination With Sunitinib Demonstrates Strong Immunologic Response That Correlates to Improved Clinical Outcomes
2. Interleukin (IL)-12 Secretion Can Predict Potency of Argos Therapeutics Arcelis™ Dendritic Cell (DC) Immunotherapy and Can Be Used as Potency Marker in Phase 3 Clinical Trial
3. Argos Therapeutics to Present Potential of its Arcelis™ Immunotherapy as an Innovative, Effective Treatment for HIV at the APHA 138th Annual Meeting & Exposition
4. Argos Therapeutics to Present Overview of its Arcelis™ Dendritic Cell-based Immunotherapy, Participate in Panel Discussion at Inaugural Cancer Immunotherapy Conference
5. Argos Therapeutics to Present Recent Clinical Developments and Corporate Overview at 18th Annual BioPartnering Europe
6. Results From Argos Therapeutics Arcelis™ Immunotherapy Phase 2 Study for Treatment of Renal Cell Carcinoma (RCC) Accepted for Poster Presentation at Ninth International Kidney Cancer Symposium
7. Cell Therapeutics, Inc. (CTI) Reports Reduction in Operating Expenses and Net Losses for Second Quarter and First Half 2011 Compared to 2010, and Advances In Bringing Pixantrone to Market
8. Michael Showalter Joins Prime Therapeutics As Chief Marketing Officer
9. Chimerix to Present at Infocasts 9th Annual Biodefense Vaccines & Therapeutics Conference
10. Life Technologies Develops Potent Drug Delivery Technology for Therapeutics Market
11. Regulus Therapeutics Appoints Gregory Hannon, Ph.D. to Scientific Advisory Board
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/24/2014)... July 24, 2014  Kinex Pharmaceuticals announced the receipt ... Company,s KX2-391 Ointment for the commencement of a Phase ... Company,s third IND to be allowed by the US ... is a synthetic, orally active and highly selective inhibitor ... promotes the induction of p53, G2/M arrest of proliferating ...
(Date:7/24/2014)...  The American Association for Homecare (AAHomecare) yesterday ... help address audit issues in the HME industry ... the information technology lead in shaping its HME ... billing and business management solutions for nearly 3,000 ... support this important initiative on behalf of all ...
(Date:7/24/2014)... Research and Markets  has announced the ... Product, Component, Application and Geography - Global Forecast to ... http://photos.prnewswire.com/prnh/20130307/600769 ... a moderate growth as the markets of the U.S. ... the saturation levels. The demand is expected to come ...
Breaking Medicine Technology:Kinex Pharmaceuticals Announces Allowance of the Investigational New Drug (IND) application for KX2-391 Ointment by the United States Food and Drug Administration (FDA) 2Kinex Pharmaceuticals Announces Allowance of the Investigational New Drug (IND) application for KX2-391 Ointment by the United States Food and Drug Administration (FDA) 3Kinex Pharmaceuticals Announces Allowance of the Investigational New Drug (IND) application for KX2-391 Ointment by the United States Food and Drug Administration (FDA) 4Brightree Joins AAHomecare as Corporate Partner and IT Lead on HME Audit Key 2Machine Health Monitoring (Vibration Monitoring, Thermography, Ultrasound Emission, Lubricating Oil Analysis, Corrosion Monitoring, Motor Current Signature Analysis) Market - Forecast to 2020 2
... Mettler-Toledo International Inc. (NYSE: MTD ) today ... Life Sciences Conference in New York on Wednesday, September 22, ... webcast of the presentation, visit the investor relations page on ... of the webcast will be available for seven days. ...
... HeartWare International, Inc. (Nasdaq: HTWR ; ... circulatory support technologies that are revolutionizing the treatment of ... is scheduled to make an investor presentation at the ... 21, at 12:30 pm EDT.  The conference will be ...
Cached Medicine Technology:HeartWare to Present at the UBS 2010 Global Life Sciences Conference 2
(Date:7/25/2014)... 2014 Innerspire, LLC ( http://www.innerspire.com ) ... as a Creative Enrollment Specialist. In this role, Greg ... as well as his accomplished design skills to further ... and to service the creative marketing needs ... work with small business owners and individuals looking to ...
(Date:7/25/2014)... 25, 2014 The American Brain Tumor ... Talent Development Trainer of Distinguished Events, and Corporate and ... American Cancer Society, will be joining the ABTA in ... Ward will oversee the roll out of a nationwide ... , The recently launched volunteer network will provide the ...
(Date:7/25/2014)... The American Brain Tumor Association (ABTA) today unveiled branding ... annual patient and family conference in Chicago. , “This ... as we – the first and now only national ... brain tumor research – extend our reach by engaging ... getting our materials and services into the hands of ...
(Date:7/25/2014)... “You have a brain tumor.” These five words ... loved ones across the U.S. every day. According to the ... typically met with confusion and uncertainty as families struggle to ... make critical decisions about a course of treatment. The shock ... a sense of isolation and a frantic and, far too ...
(Date:7/25/2014)... Chicago, IL (PRWEB) July 25, 2014 There ... tumor, and 500 diagnosed each day. Though when someone hears ... alone, confused and are unsure of the next step and ... is helping people figure out that next step by providing ... knows this more than Brian Olson, member of the ABTA’s ...
Breaking Medicine News(10 mins):Health News:Innerspire, LLC Continues National Expansion 2Health News:Innerspire, LLC Continues National Expansion 3Health News:Innerspire, LLC Continues National Expansion 4Health News:American Brain Tumor Association Recruits Director to Lead New Volunteer Network 2Health News:American Brain Tumor Association Unveils Brand Identity for Newly Launched Volunteer Network 2Health News:American Brain Tumor Association Unveils Brand Identity for Newly Launched Volunteer Network 3Health News:American Brain Tumor Association to Expand Service Reach with Launch of Nationwide Volunteer Network 2Health News:American Brain Tumor Association to Expand Service Reach with Launch of Nationwide Volunteer Network 3Health News:American Brain Tumor Association Board of Directors Member Shares Story of Brain Tumor Survivorship 2Health News:American Brain Tumor Association Board of Directors Member Shares Story of Brain Tumor Survivorship 3
... , WEDNESDAY, Sept. 14 (HealthDay News) -- ... new research suggests that people who kick the habit ... from the University of Missouri found that smoking is ... (often being emotionally negative and anxious) among adults under ...
... Alexandria, Va., USA - The International and American ... proceedings from the 3rd AADR Fall Focused Symposium ... symposium was held November 12-13, 2010, in Washington, ... Symposium under the objective to provide networking opportunities ...
... Division of Pain Medicine in the Department of ... Neurological Institute have each received 2011 Medical & ... Institutions for these nationally competitive awards are reviewed ... comprised of leaders in the field. The ...
... likely than Caucasians to be not only diagnosed with head and ... answer isn,t a simple one, differences in lifestyle, access to care ... a new study from Henry Ford Hospital. The study also ... current smokers, one of the primary risk factors for head and ...
... , WEDNESDAY, Sept. 14 (HealthDay News) -- For ... on staff, "telestroke" may be a cost-effective option to ... say. Telestroke, or virtual stroke care, ... through two-way audio-video equipment. "In an era of ...
... The human papillomavirus (HPV) is more likely to be ... and those with private health insurance, according to a new ... also reveals that laryngeal cancer patients with Medicare, who tend ... HPV, suggesting that HPV infection may be closely tied to ...
Cached Medicine News:Health News:Quitting Smoking May Improve Personality, Study Suggests 2Health News:IADR/AADR publish proceedings from the AADR Fall Focused Symposium on Salivary Diagnostics 2Health News:Genetics, lifestyle provide clues to racial differences in head and neck cancer 2Health News:Genetics, lifestyle provide clues to racial differences in head and neck cancer 3Health News:Rural Stroke Victims May Benefit From 'Virtual' Care 2Health News:Gender, insurance type tied to HPV infection in laryngeal cancer patients 2Health News:Gender, insurance type tied to HPV infection in laryngeal cancer patients 3
Dust covers for a variety of Zeiss microscopes...
Inquire...
... An economical laboratory tissue culture microscope, ... to expand their applications. Olympus has taken ... the CKX41. Fluorescence can be used with ... images can be carried out on the ...
... Designed for the scientist who wants ... the TE2000E2 is a high precision Z-focus ... This makes it possible to expand ... sources and image outputs. A five-way ...
Medicine Products: